Add to Favorites Newsroom RSS Share
fb-shareSanford Burnham Prebys Medical Discovery Institute
La Jolla, CA USA

Our News on Newswise

Newswise: Zeev_Ronai_profile.jpg

One-two punch drug combination offers hope for pancreatic cancer therapy

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified a combination of two anti-cancer compounds that shrank pancreatic tumors in mice—supporting the immediate evaluation of the drugs in a clinical trial. U.S. Food and...
18-Nov-2019 11:00 AM EST Add to Favorites

Newswise: Anthony-Pinkerton.jpg

Sanford Burnham Prebys awarded $3.58 million NIH grant to advance potential treatment for opioid-use disorders

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $3.58 million grant to Sanford Burnham Prebys scientist Anthony Pinkerton, Ph.D., to advance a potential treatment for opioid-use disorders,...
21-Oct-2019 1:35 PM EDT Add to Favorites

Machine Learning’s Next Frontier: Epigenetic Drug Discovery

Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a machine-learning algorithm that gleans information from microscope images—allowing for high-throughput epigenetic drug screens that could unlock new treatments for...
22-Oct-2019 8:00 AM EDT Add to Favorites

Newswise: jerold-chun-8160.jpg

New Insights Into How to Protect Premature Babies From Common Brain Disorder

Premature babies have delicate brain tissue that is prone to bleeding and can result in post-hemorrhagic hydrocephalus, a dangerous condition that leads to excess fluid accumulation and brain dysfunction. Now, scientists from Sanford Burnham Prebys...
8-Oct-2019 4:05 PM EDT Add to Favorites

Newswise: EvanSnyder.jpg

$4.96 Million CIRM Grant Awarded to Sanford Burnham Prebys to Help the Tiniest Patients

The California Institute for Regenerative Medicine (CIRM) has awarded a $4.96 million grant to Sanford Burnham Prebys Professor Evan Y. Snyder, M.D., Ph.D. The funding will allow Snyder to complete pre-investigational new drug (IND)-enabling...
19-Aug-2019 8:00 AM EDT Add to Favorites

Sanford Burnham Prebys expands collaboration with Lilly to investigate immunological therapies

Sanford Burnham Prebys Medical Discovery Institute today announced a three-year extension to its existing collaboration with Eli Lilly and Company (Lilly) to discover and develop immunological therapies. The goals of the agreement are to advance...
14-Aug-2019 8:00 AM EDT Add to Favorites

Newswise: ISSCRimage_cropped.jpg

Functional Hair Follicles Grown from Stem Cells

Scientists from Sanford Burnham Prebys have created natural-looking hair that grows through the skin using human induced pluripotent stem cells (iPSCs), a major scientific achievement that could revolutionize the hair growth industry. The findings...
25-Jun-2019 2:00 PM EDT Add to Favorites

Newswise: C.C.profile.jpg

Nutritional Cues Regulate Pancreatic Tumor’s “Cell Drinking”

Desperate for nutrients, rapidly growing pancreatic tumors resort to scavenging “fuel” through an alternative supply route, called macropinocytosis. Blocking this process, often described as “cellular drinking,” could lead to tumor-starving...
20-Jun-2019 4:55 PM EDT Add to Favorites

see all news

Our YouTube Videos


Sanford Burnham Prebys is a preeminent, independent biomedical research institute dedicated to understanding human biology and disease and advancing scientific discoveries to profoundly impact human health. For over 40 years, our research has produced breakthroughs in cancer, neuroscience, immunology and children’s diseases, and is anchored by our NCI-designated cancer center and advanced drug discovery capabilities. For more information, visit us at or on Facebook at and on Twitter @SBPdiscovery.


  • Evan Snyder

    Professor & Director - Stem Cell Regenerative Med.

    Stem Cells, Spinal Cord Injury, Parkinson's Disease, ALS, Bipolar Disorder
  • Jerold Chun

    Professor & Senior VP- Neuroscience Drug Discovery

    Neuroscience, Alzheimer's Disease, Multiple Sclerosis (MS), Parkinson's Disease


Monica May
Science Writer


Deborah Robison
Vice President, Communications


Karli Schwab
Communications Coordinator


Twitter twitter-icon

Chat now!